Vault-13

SAMSARA BIOCAPITAL, LLC

PALO ALTO, CA · CIK 1744967 · 13F filing filed 2023-08-14

SEC-registered investment adviser since 2018 · limited liability company

As an employer

US visa salary filings

Job titleFilingsMedianRange
Senior AssociatePalo Alto, CA 2 $187,500 $175,000 – $200,000

Source: US Department of Labor, Labor Condition Application disclosure data (certified, full-time, yearly equivalent). These are the salaries the employer committed to pay the visa roles it filed for, at least the prevailing wage for the job and place; they are not the pay of all its staff. Filed by: Samsara BioCapital, LLC.

$569.7m reported value +17.8% vs Q1 2023
47positions
79.1%in top 10
2 new 1 added 9 reduced 11 sold out vs Q1 2023

Holdings, Q2 2023

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 CHINOOK THERAPEUTICS INC COM ADRO ADRO 5,161,888 $198.3m34.81% 34.81% UnchangedShares held: Q3 2022 5.2m, Q4 2022 5.2m, Q1 2023 5.2m, Q2 2023 5.2m
2 MINERALYS THERAPEUTICS INC COM MLYS MLYS 4,519,361 $77.1m13.52% 13.52% UnchangedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 4.5m, Q2 2023 4.5m
3 ACELYRIN INC COM COM 2,256,022 $47.2m8.28% 8.28% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 2.3m
4 SCHOLAR ROCK HLDG CORP COM SRRK SRRK 4,598,828 $34.7m6.09% 6.09% UnchangedShares held: Q3 2022 4.6m, Q4 2022 4.6m, Q1 2023 4.6m, Q2 2023 4.6m
5 GRAPHITE BIO INC COM GRPH GRPH 8,459,314 $22.0m3.86% 3.86% UnchangedShares held: Q3 2022 8.5m, Q4 2022 8.5m, Q1 2023 8.5m, Q2 2023 8.5m
6 ARCELLX INC COMMON STOCK ACLX ACLX 613,921 $19.4m3.41% 3.41% ReducedShares held: Q3 2022 1.1m, Q4 2022 957.5k, Q1 2023 909.6k, Q2 2023 613.9k -295.7k -295,658 -32.5%
7 AVADEL PHARMACEUTICALS PLC SPONSORED ADR SPONSORED ADR 967,527 $15.9m2.80% 2.80% ReducedShares held: Q3 2022 659.4k, Q4 2022 659.4k, Q1 2023 1.4m, Q2 2023 967.5k -441.9k -441,882 -31.4%
8 ZYMEWORKS INC COM ZYME ZYME 1,458,875 $12.6m2.21% 2.21% ReducedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 1.6m, Q2 2023 1.5m -161.8k -161,812 -10.0%
9 IVERIC BIO INC COM OPHT OPHT 308,151 $12.1m2.13% 2.13% ReducedShares held: Q3 2022 808.0k, Q4 2022 808.0k, Q1 2023 686.8k, Q2 2023 308.2k -378.7k -378,684 -55.1%
10 LYRA THERAPEUTICS INC COM LYRA LYRA 2,780,261 $11.4m2.01% 2.01% AddedShares held: Q3 2022 1.8m, Q4 2022 1.8m, Q1 2023 1.8m, Q2 2023 2.8m +1.0m +1,003,010 56.4%
11 HILLEVAX INC COM COM 599,274 $10.3m1.81% 1.81% ReducedShares held: Q3 2022 610.1k, Q4 2022 610.1k, Q1 2023 609.9k, Q2 2023 599.3k -10.6k -10,588 -1.7%
12 DICE THERAPEUTICS INC COM COM 202,773 $9.4m1.65% 1.65% UnchangedShares held: Q3 2022 253.5k, Q4 2022 202.8k, Q1 2023 202.8k, Q2 2023 202.8k
13 SUTRO BIOPHARMA INC COM COM 1,675,579 $7.8m1.37% 1.37% UnchangedShares held: Q3 2022 1.7m, Q4 2022 1.7m, Q1 2023 1.7m, Q2 2023 1.7m
14 VERONA PHARMA PLC SPONSORED ADS VRNA VRNA 347,500 $7.3m1.29% 1.29% ReducedShares held: Q3 2022 938.9k, Q4 2022 695.0k, Q1 2023 695.0k, Q2 2023 347.5k -347.5k -347,501 -50.0%
15 ACLARIS THERAPEUTICS INC COM ACRS ACRS 696,171 $7.2m1.27% 1.27% UnchangedShares held: Q3 2022 696.2k, Q4 2022 696.2k, Q1 2023 696.2k, Q2 2023 696.2k
16 INTERCEPT PHARMACEUTICALS IN COM ICPT ICPT 640,688 $7.1m1.24% 1.24% UnchangedShares held: Q3 2022 640.7k, Q4 2022 640.7k, Q1 2023 640.7k, Q2 2023 640.7k
17 PRIME MEDICINE INC COM PRME PRME 470,304 $6.9m1.21% 1.21% UnchangedShares held: Q3 2022 0, Q4 2022 470.3k, Q1 2023 470.3k, Q2 2023 470.3k
18 NKARTA INC COM NKTX NKTX 2,868,035 $6.3m1.10% 1.10% UnchangedShares held: Q3 2022 2.9m, Q4 2022 2.9m, Q1 2023 2.9m, Q2 2023 2.9m
19 PEPGEN INC COM PEPG PEPG 651,050 $5.8m1.02% 1.02% UnchangedShares held: Q3 2022 651.0k, Q4 2022 651.0k, Q1 2023 651.0k, Q2 2023 651.0k
20 RHYTHM PHARMACEUTICALS INC COM RYTM RYTM 345,293 $5.7m1.00% 1.00% UnchangedShares held: Q3 2022 345.3k, Q4 2022 345.3k, Q1 2023 345.3k, Q2 2023 345.3k
21 IMMUNOCORE HLDGS PLC ADS IMCR IMCR 80,963 $4.9m0.85% 0.85% UnchangedShares held: Q3 2022 81.0k, Q4 2022 81.0k, Q1 2023 81.0k, Q2 2023 81.0k
22 IMMATICS N.V SHS IMTX IMTX 396,000 $4.6m0.80% 0.80% ReducedShares held: Q3 2022 0, Q4 2022 495.0k, Q1 2023 495.0k, Q2 2023 396.0k -99.0k -99,000 -20.0%
23 JANUX THERAPEUTICS INC COM JANX JANX 360,414 $4.3m0.75% 0.75% UnchangedShares held: Q3 2022 360.4k, Q4 2022 360.4k, Q1 2023 360.4k, Q2 2023 360.4k
24 EYEPOINT PHARMACEUTICALS INC COM NEW EYPT EYPT 432,000 $3.8m0.66% 0.66% ReducedShares held: Q3 2022 480.0k, Q4 2022 480.0k, Q1 2023 480.0k, Q2 2023 432.0k -48.0k -48,000 -10.0%
25 DECIBEL THERAPEUTICS INC COM COM 801,629 $3.1m0.54% 0.54% UnchangedShares held: Q3 2022 801.6k, Q4 2022 801.6k, Q1 2023 801.6k, Q2 2023 801.6k
26 SYROS PHARMACEUTICALS INC COM NEW SYRS SYRS 881,450 $2.8m0.49% 0.49% UnchangedShares held: Q3 2022 0, Q4 2022 881.5k, Q1 2023 881.5k, Q2 2023 881.5k
27 RAIN ONCOLOGY INC COM COM 2,034,552 $2.4m0.43% 0.43% ReducedShares held: Q3 2022 1.6m, Q4 2022 2.3m, Q1 2023 2.3m, Q2 2023 2.0m -226.1k -226,100 -10.0%
28 DAY ONE BIOPHARMACEUTICALS I COM COM 196,425 $2.3m0.41% 0.41% UnchangedShares held: Q3 2022 196.4k, Q4 2022 196.4k, Q1 2023 196.4k, Q2 2023 196.4k
29 TANGO THERAPEUTICS INC COM TNGX TNGX 630,000 $2.1m0.37% 0.37% UnchangedShares held: Q3 2022 630.0k, Q4 2022 630.0k, Q1 2023 630.0k, Q2 2023 630.0k
30 IO BIOTECH INC COM IOBTQ IOBTQ 1,008,437 $2.0m0.35% 0.35% UnchangedShares held: Q3 2022 1.0m, Q4 2022 1.0m, Q1 2023 1.0m, Q2 2023 1.0m
31 LEAP THERAPEUTICS INC COM NEW CYPH CYPH 602,203 $1.9m0.33% 0.33% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 602.2k
32 TERNS PHARMACEUTICALS INC COM COM 202,348 $1.8m0.31% 0.31% UnchangedShares held: Q3 2022 289.1k, Q4 2022 202.3k, Q1 2023 202.3k, Q2 2023 202.3k
33 IGM BIOSCIENCES INC COM IGMS IGMS 154,664 $1.4m0.25% 0.25% UnchangedShares held: Q3 2022 154.7k, Q4 2022 154.7k, Q1 2023 154.7k, Q2 2023 154.7k
34 BOLT BIOTHERAPEUTICS INC COM COM 1,049,153 $1.3m0.24% 0.24% UnchangedShares held: Q3 2022 1.0m, Q4 2022 1.0m, Q1 2023 1.0m, Q2 2023 1.0m
35 ELEVATION ONCOLOGY INC COM COM 830,565 $1.3m0.22% 0.22% UnchangedShares held: Q3 2022 830.6k, Q4 2022 830.6k, Q1 2023 830.6k, Q2 2023 830.6k
36 VTV THERAPEUTICS INC CL A VTVT VTVT 1,635,509 $1.2m0.21% 0.21% UnchangedShares held: Q3 2022 1.6m, Q4 2022 1.6m, Q1 2023 1.6m, Q2 2023 1.6m
37 INSTIL BIO INC COM COM 1,788,280 $985.3k0.17% 0.17% UnchangedShares held: Q3 2022 1.8m, Q4 2022 1.8m, Q1 2023 1.8m, Q2 2023 1.8m
38 VIRACTA THERAPEUTICS INC COM SNSS SNSS 689,709 $972.5k0.17% 0.17% UnchangedShares held: Q3 2022 689.7k, Q4 2022 689.7k, Q1 2023 689.7k, Q2 2023 689.7k
39 ALLAKOS INC COM ALLKG ALLKG 172,089 $750.3k0.13% 0.13% UnchangedShares held: Q3 2022 172.1k, Q4 2022 172.1k, Q1 2023 172.1k, Q2 2023 172.1k
40 AEGLEA BIOTHERAPEUTICS INC COM AGLE AGLE 883,720 $398.1k0.07% 0.07% UnchangedShares held: Q3 2022 883.7k, Q4 2022 883.7k, Q1 2023 883.7k, Q2 2023 883.7k
41 ALLOVIR INC COM COM 82,336 $279.9k0.05% 0.05% UnchangedShares held: Q3 2022 82.3k, Q4 2022 82.3k, Q1 2023 82.3k, Q2 2023 82.3k
42 ASTRIA THERAPEUTICS INC COM CATB CATB 25,000 $208.2k0.04% 0.04% UnchangedShares held: Q3 2022 25.0k, Q4 2022 25.0k, Q1 2023 25.0k, Q2 2023 25.0k
43 SCIENCE 37 HOLDINGS INC COM COM 900,000 $191.2k0.03% 0.03% UnchangedShares held: Q3 2022 900.0k, Q4 2022 900.0k, Q1 2023 900.0k, Q2 2023 900.0k
44 NOVAVAX INC COM NEW NVAX NVAX 21,244 $157.8k0.03% 0.03% UnchangedShares held: Q3 2022 21.2k, Q4 2022 21.2k, Q1 2023 21.2k, Q2 2023 21.2k
45 KRONOS BIO INC COM KRON KRON 78,131 $134.4k0.02% 0.02% UnchangedShares held: Q3 2022 78.1k, Q4 2022 78.1k, Q1 2023 78.1k, Q2 2023 78.1k
46 NUVATION BIO INC *W EXP 07/07/202 NUVB.WS NUVB.WS 133,333 $22.1k0.00% 0.00% UnchangedShares held: Q3 2022 133.3k, Q4 2022 133.3k, Q1 2023 133.3k, Q2 2023 133.3k
47 SURROZEN INC *W EXP 08/01/203 *W EXP 08/01/203 99,999 $5.5k0.00% 0.00% UnchangedShares held: Q3 2022 100.0k, Q4 2022 100.0k, Q1 2023 100.0k, Q2 2023 100.0k

Sold out since Q1 2023

SecurityTickerShares held beforeValue then
CENTESSA PHARMACEUTICALS PLC 1,693,736 $6.5m1.7m shares
AMRYT PHARMA PLC 304,715 $4.4m304.7k shares
ATYR PHARMA INC ATYR ATYR 1,750,000 $3.7m1.8m shares
INOZYME PHARMA INC 504,407 $2.9m504.4k shares
ALX ONCOLOGY HLDGS INC ALXO ALXO 262,786 $1.2m262.8k shares
EQUILLIUM INC EQ EQ 615,541 $449.3k615.5k shares
ATRECA INC BCEL BCEL 262,827 $299.6k262.8k shares
LEAP THERAPEUTICS INC LPTX LPTX 846,038 $287.7k846.0k shares
KALA BIO INC 12,024 $181.0k12.0k shares
SURROZEN INC 300,000 $180.6k300.0k shares
NGM BIOPHARMACEUTICALS INC NGM NGM 13,669 $55.8k13.7k shares